BioSpace News Archive

Business

SpringWorks Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights

SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, reported second quarter financial results for the period ended June 30, 2022 and provided an update on recent company developments.

August 4, 2022
·
15 min read
BioMidwest

Bio-Techne Declares Dividend - Aug 04, 2022

Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2022.

August 4, 2022
·
2 min read
Business

Immunic, Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Immunic, Inc., a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, announced financial results for the second quarter ended June 30, 2022 and provided a corporate update.

August 4, 2022
·
16 min read
Business

InfuSystem Reports Second Quarter 2022 Financial Results

InfuSystem Holdings, Inc., a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, reported financial results for the second quarter ended June 30, 2022.

August 4, 2022
·
24 min read
Bio NC

Asensus Surgical Announces Sale of Senhance Robotic System

Asensus Surgical, Inc. announced that a Senhance® Surgical System was sold to the Company’s distribution partner, and will be placed in a hospital in the Commonwealth of Independent States region.

August 4, 2022
·
4 min read
Business

NovaBay Pharmaceuticals to Hold Second Quarter 2022 Conference Call on August 11

NovaBay® Pharmaceuticals, Inc. announces that it will report financial results for the three and six months ended June 30, 2022 after market close on Thursday, August 11, 2022 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.

August 4, 2022
·
2 min read
Biotech Beach

Poseida Therapeutics Announces Proposed Public Offering of Common Stock - Aug 04, 2022

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, announced that it has commenced an underwritten public offering of shares of its common stock.

August 4, 2022
·
4 min read
Business

Compugen Reports Second Quarter 2022 Results

Compugen Ltd., a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, provided a corporate update and announced financial results for the second quarter ended June 30, 2022.

August 4, 2022
·
11 min read
Genetown

Seres Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference

Seres Therapeutics, Inc., a leading microbiome therapeutics company, announced that Eric Shaff, President and Chief Executive Officer, will participate in a discussion at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10 at 12:30 p.m. ET.

August 4, 2022
·
1 min read
Tissue Microarray Market, 2031: Growing Rate of Technological Advancements and the Adoption of the Microarray Technique

The tissue microarray market has been anticipated to grow at a significant speed in the years to come.

August 4, 2022
·
6 min read